- call +1-201-465-4211
- email sales@mrinsights.biz
According to this latest study, the 2021 growth of Vaccine Adjuvants will have significant change from previous year. By the most conservative estimates of global Vaccine Adjuvants market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 745.4 million in 2020. Over the next five years the Vaccine Adjuvants market will register a 10.6% CAGR in terms of revenue, the global market size will reach US$ 1114.6 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine Adjuvants market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Oral
Subcutaneous
Intramuscular
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
Human Vaccine Adjuvants (Research Applications, Commercial Applications)
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
SEPPIC
SDA BIO
Croda International Plc
SPI Pharma
Phibro Animal Health Corporation
Tj Kaiwei
Novavax
Zhuoyue
Aphios
GSK
CSL Limited
Brenntag Biosector
SEPPIC
SPI Pharma
Novavax
Avanti Polar Lipids
Aphios
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vaccine Adjuvants Consumption 2016-2026
2.1.2 Vaccine Adjuvants Consumption CAGR by Region
2.2 Vaccine Adjuvants Segment by Type
2.2.1 Oral
2.2.2 Subcutaneous
2.2.3 Intramuscular
2.2.4 Others
2.3 Vaccine Adjuvants Sales by Type
2.3.1 Global Vaccine Adjuvants Sales Market Share by Type (2016-2021)
2.3.2 Global Vaccine Adjuvants Revenue and Market Share by Type (2016-2021)
2.3.3 Global Vaccine Adjuvants Sale Price by Type (2016-2021)
2.4 Vaccine Adjuvants Segment by Application
2.4.1 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
2.4.2 Human Vaccine Adjuvants (Research Applications, Commercial Applications)
2.5 Vaccine Adjuvants Sales by Application
2.5.1 Global Vaccine Adjuvants Sale Market Share by Application (2016-2021)
2.5.2 Global Vaccine Adjuvants Revenue and Market Share by Application (2016-2021)
2.5.3 Global Vaccine Adjuvants Sale Price by Application (2016-2021)
3 Global Vaccine Adjuvants by Company
3.1 Global Vaccine Adjuvants Sales Market Share by Company
3.1.1 Global Vaccine Adjuvants Sales by Company (2019-2021)
3.1.2 Global Vaccine Adjuvants Sales Market Share by Company (2019-2021)
3.2 Global Vaccine Adjuvants Revenue Market Share by Company
3.2.1 Global Vaccine Adjuvants Revenue by Company (2019-2021)
3.2.2 Global Vaccine Adjuvants Revenue Market Share by Company (2019-2021)
3.3 Global Vaccine Adjuvants Sale Price by Company
3.4 Global Manufacturers Vaccine Adjuvants Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vaccine Adjuvants Product Location Distribution
3.4.2 Players Vaccine Adjuvants Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Vaccine Adjuvants by Region
4.1 Global Vaccine Adjuvants by Region
4.1.1 Global Vaccine Adjuvants Sales by Region
4.1.2 Global Vaccine Adjuvants Revenue by Region
4.2 Americas Vaccine Adjuvants Sales Growth
4.3 APAC Vaccine Adjuvants Sales Growth
4.4 Europe Vaccine Adjuvants Sales Growth
4.5 Middle East & Africa Vaccine Adjuvants Sales Growth
5 Americas
5.1 Americas Vaccine Adjuvants Sales by Country
5.1.1 Americas Vaccine Adjuvants Sales by Country (2016-2021)
5.1.2 Americas Vaccine Adjuvants Revenue by Country (2016-2021)
5.2 Americas Vaccine Adjuvants Sales by Type
5.3 Americas Vaccine Adjuvants Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine Adjuvants Sales by Region
6.1.1 APAC Vaccine Adjuvants Sales by Region (2016-2021)
6.1.2 APAC Vaccine Adjuvants Revenue by Region (2016-2021)
6.2 APAC Vaccine Adjuvants Sales by Type
6.3 APAC Vaccine Adjuvants Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Vaccine Adjuvants by Country
7.1.1 Europe Vaccine Adjuvants Sales by Country (2016-2021)
7.1.2 Europe Vaccine Adjuvants Revenue by Country (2016-2021)
7.2 Europe Vaccine Adjuvants Sales by Type
7.3 Europe Vaccine Adjuvants Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Vaccine Adjuvants by Country
8.1.1 Middle East & Africa Vaccine Adjuvants Sales by Country (2016-2021)
8.1.2 Middle East & Africa Vaccine Adjuvants Revenue by Country (2016-2021)
8.2 Middle East & Africa Vaccine Adjuvants Sales by Type
8.3 Middle East & Africa Vaccine Adjuvants Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Vaccine Adjuvants Distributors
10.3 Vaccine Adjuvants Customer
11 Global Vaccine Adjuvants Market Forecast
11.1 Global Vaccine Adjuvants Forecast by Region
11.1.1 Global Vaccine Adjuvants Forecast by Regions (2021-2026)
11.2.2 Global Vaccine Adjuvants Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Vaccine Adjuvants Forecast by Type
11.7 Global Vaccine Adjuvants Forecast by Application
12 Key Players Analysis
12.1 SEPPIC
12.1.1 SEPPIC Company Information
12.1.2 SEPPIC Vaccine Adjuvants Product Offered
12.1.3 SEPPIC Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 SEPPIC Main Business Overview
12.1.5 SEPPIC Latest Developments
12.2 SDA BIO
12.2.1 SDA BIO Company Information
12.2.2 SDA BIO Vaccine Adjuvants Product Offered
12.2.3 SDA BIO Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 SDA BIO Main Business Overview
12.2.5 SDA BIO Latest Developments
12.3 Croda International Plc
12.3.1 Croda International Plc Company Information
12.3.2 Croda International Plc Vaccine Adjuvants Product Offered
12.3.3 Croda International Plc Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Croda International Plc Main Business Overview
12.3.5 Croda International Plc Latest Developments
12.4 SPI Pharma
12.4.1 SPI Pharma Company Information
12.4.2 SPI Pharma Vaccine Adjuvants Product Offered
12.4.3 SPI Pharma Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 SPI Pharma Main Business Overview
12.4.5 SPI Pharma Latest Developments
12.5 Phibro Animal Health Corporation
12.5.1 Phibro Animal Health Corporation Company Information
12.5.2 Phibro Animal Health Corporation Vaccine Adjuvants Product Offered
12.5.3 Phibro Animal Health Corporation Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Phibro Animal Health Corporation Main Business Overview
12.5.5 Phibro Animal Health Corporation Latest Developments
12.6 Tj Kaiwei
12.6.1 Tj Kaiwei Company Information
12.6.2 Tj Kaiwei Vaccine Adjuvants Product Offered
12.6.3 Tj Kaiwei Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Tj Kaiwei Main Business Overview
12.6.5 Tj Kaiwei Latest Developments
12.7 Novavax
12.7.1 Novavax Company Information
12.7.2 Novavax Vaccine Adjuvants Product Offered
12.7.3 Novavax Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Novavax Main Business Overview
12.7.5 Novavax Latest Developments
12.8 Zhuoyue
12.8.1 Zhuoyue Company Information
12.8.2 Zhuoyue Vaccine Adjuvants Product Offered
12.8.3 Zhuoyue Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Zhuoyue Main Business Overview
12.8.5 Zhuoyue Latest Developments
12.9 Aphios
12.9.1 Aphios Company Information
12.9.2 Aphios Vaccine Adjuvants Product Offered
12.9.3 Aphios Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Aphios Main Business Overview
12.9.5 Aphios Latest Developments
12.10 GSK
12.10.1 GSK Company Information
12.10.2 GSK Vaccine Adjuvants Product Offered
12.10.3 GSK Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 GSK Main Business Overview
12.10.5 GSK Latest Developments
12.11 CSL Limited
12.11.1 CSL Limited Company Information
12.11.2 CSL Limited Vaccine Adjuvants Product Offered
12.11.3 CSL Limited Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 CSL Limited Main Business Overview
12.11.5 CSL Limited Latest Developments
12.12 Brenntag Biosector
12.12.1 Brenntag Biosector Company Information
12.12.2 Brenntag Biosector Vaccine Adjuvants Product Offered
12.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Brenntag Biosector Main Business Overview
12.12.5 Brenntag Biosector Latest Developments
12.13 SEPPIC
12.13.1 SEPPIC Company Information
12.13.2 SEPPIC Vaccine Adjuvants Product Offered
12.13.3 SEPPIC Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 SEPPIC Main Business Overview
12.13.5 SEPPIC Latest Developments
12.14 SPI Pharma
12.14.1 SPI Pharma Company Information
12.14.2 SPI Pharma Vaccine Adjuvants Product Offered
12.14.3 SPI Pharma Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 SPI Pharma Main Business Overview
12.14.5 SPI Pharma Latest Developments
12.15 Novavax
12.15.1 Novavax Company Information
12.15.2 Novavax Vaccine Adjuvants Product Offered
12.15.3 Novavax Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Novavax Main Business Overview
12.15.5 Novavax Latest Developments
12.16 Avanti Polar Lipids
12.16.1 Avanti Polar Lipids Company Information
12.16.2 Avanti Polar Lipids Vaccine Adjuvants Product Offered
12.16.3 Avanti Polar Lipids Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Avanti Polar Lipids Main Business Overview
12.16.5 Avanti Polar Lipids Latest Developments
12.17 Aphios
12.17.1 Aphios Company Information
12.17.2 Aphios Vaccine Adjuvants Product Offered
12.17.3 Aphios Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Aphios Main Business Overview
12.17.5 Aphios Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Vaccine Adjuvants Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Subcutaneous
Table 4. Major Players of Intramuscular
Table 5. Major Players of Others
Table 6. Global Vaccine Adjuvants Sales by Type (2016-2021) & (Kg)
Table 7. Global Vaccine Adjuvants Sales Market Share by Type (2016-2021)
Table 8. Global Vaccine Adjuvants Revenue by Type (2016-2021) & ($ million)
Table 9. Global Vaccine Adjuvants Revenue Market Share by Type (2016-2021)
Table 10. Global Vaccine Adjuvants Sale Price by Type (2016-2021)
Table 11. Global Vaccine Adjuvants Sales by Application (2016-2021) & (Kg)
Table 12. Global Vaccine Adjuvants Sales Market Share by Application (2016-2021)
Table 13. Global Vaccine Adjuvants Value by Application (2016-2021)
Table 14. Global Vaccine Adjuvants Revenue Market Share by Application (2016-2021)
Table 15. Global Vaccine Adjuvants Sale Price by Application (2016-2021)
Table 16. Global Vaccine Adjuvants Sales by Company (2019-2021) & (Kg)
Table 17. Global Vaccine Adjuvants Sales Market Share by Company (2019-2021)
Table 18. Global Vaccine Adjuvants Revenue by Company (2019-2021) ($ Millions)
Table 19. Global Vaccine Adjuvants Revenue Market Share by Company (2019-2021)
Table 20. Global Vaccine Adjuvants Sale Price by Company (2019-2021)
Table 21. Key Manufacturers Vaccine Adjuvants Producing Area Distribution and Sales Area
Table 22. Players Vaccine Adjuvants Products Offered
Table 23. Vaccine Adjuvants Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Vaccine Adjuvants Sales by Region (2016-2021) (Kg)
Table 27. Global Vaccine Adjuvants Sales Market Share by Region (2016-2021)
Table 28. Global Vaccine Adjuvants Revenue by Region (2016-2021) & ($ Millions)
Table 29. Global Vaccine Adjuvants Revenue Market Share by Region (2016-2021)
Table 30. Americas Vaccine Adjuvants Sales by Country (2016-2021) & (Kg)
Table 31. Americas Vaccine Adjuvants Sales Market Share by Country (2016-2021)
Table 32. Americas Vaccine Adjuvants Revenue by Country (2016-2021) & ($ Millions)
Table 33. Americas Vaccine Adjuvants Revenue Market Share by Country (2016-2021)
Table 34. Americas Vaccine Adjuvants Sales by Type (2016-2021) & (Kg)
Table 35. Americas Vaccine Adjuvants Sales Market Share by Type (2016-2021)
Table 36. Americas Vaccine Adjuvants Sales by Application (2016-2021) & (Kg)
Table 37. Americas Vaccine Adjuvants Sales Market Share by Application (2016-2021)
Table 38. APAC Vaccine Adjuvants Sales by Region (2016-2021) & (Kg)
Table 39. APAC Vaccine Adjuvants Sales Market Share by Region (2016-2021)
Table 40. APAC Vaccine Adjuvants Revenue by Region (2016-2021) & ($ Millions)
Table 41. APAC Vaccine Adjuvants Revenue Market Share by Region (2016-2021)
Table 42. APAC Vaccine Adjuvants Sales by Type (2016-2021) & (Kg)
Table 43. APAC Vaccine Adjuvants Sales Market Share by Type (2016-2021)
Table 44. APAC Vaccine Adjuvants Sales by Application (2016-2021) & (Kg)
Table 45. APAC Vaccine Adjuvants Sales Market Share by Application (2016-2021)
Table 46. Europe Vaccine Adjuvants Sales by Country (2016-2021) & (Kg)
Table 47. Europe Vaccine Adjuvants Sales Market Share by Country (2016-2021)
Table 48. Europe Vaccine Adjuvants Revenue by Country (2016-2021) & ($ Millions)
Table 49. Europe Vaccine Adjuvants Revenue Market Share by Country (2016-2021)
Table 50. Europe Vaccine Adjuvants Sales by Type (2016-2021) & (Kg)
Table 51. Europe Vaccine Adjuvants Sales Market Share by Type (2016-2021)
Table 52. Europe Vaccine Adjuvants Sales by Application (2016-2021) & (Kg)
Table 53. Europe Vaccine Adjuvants Sales Market Share by Application (2016-2021)
Table 54. Middle East & Africa Vaccine Adjuvants Sales by Country (2016-2021) & (Kg)
Table 55. Middle East & Africa Vaccine Adjuvants Sales Market Share by Country (2016-2021)
Table 56. Middle East & Africa Vaccine Adjuvants Revenue by Country (2016-2021) & ($ Millions)
Table 57. Middle East & Africa Vaccine Adjuvants Revenue Market Share by Country (2016-2021)
Table 58. Middle East & Africa Vaccine Adjuvants Sales by Type (2016-2021) & (Kg)
Table 59. Middle East & Africa Vaccine Adjuvants Sales Market Share by Type (2016-2021)
Table 60. Middle East & Africa Vaccine Adjuvants Sales by Application (2016-2021) & (Kg)
Table 61. Middle East & Africa Vaccine Adjuvants Sales Market Share by Application (2016-2021)
Table 62. Key and Potential Regions of Vaccine Adjuvants
Table 63. Key Application and Potential Industries of Vaccine Adjuvants
Table 64. Key Challenges of Vaccine Adjuvants
Table 65. Key Trends of Vaccine Adjuvants
Table 66. Vaccine Adjuvants Distributors List
Table 67. Vaccine Adjuvants Customer List
Table 68. Global Vaccine Adjuvants Sales Forecast by Region (2021-2026) & (Kg)
Table 69. Global Vaccine Adjuvants Consumption Market Forecast by Region
Table 70. Global Vaccine Adjuvants Revenue Forecast by Region (2021-2026) & ($ millions)
Table 71. Global Vaccine Adjuvants Revenue Market Share Forecast by Region (2021-2026)
Table 72. Americas Vaccine Adjuvants Sales Forecast by Country (2021-2026) & (Kg)
Table 73. Americas Vaccine Adjuvants Revenue Forecast by Country (2021-2026) & ($ millions)
Table 74. APAC Vaccine Adjuvants Sales Forecast by Region (2021-2026) & (Kg)
Table 75. APAC Vaccine Adjuvants Revenue Forecast by Region (2021-2026) & ($ millions)
Table 76. Europe Vaccine Adjuvants Sales Forecast by Country (2021-2026) & (Kg)
Table 77. Europe Vaccine Adjuvants Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Middle East & Africa Vaccine Adjuvants Sales Forecast by Country (2021-2026) & (Kg)
Table 79. Middle East & Africa Vaccine Adjuvants Revenue Forecast by Country (2021-2026) & ($ millions)
Table 80. Global Vaccine Adjuvants Sales Forecast by Type (2021-2026) & (Kg)
Table 81. Global Vaccine Adjuvants Sales Market Share Forecast by Type (2021-2026)
Table 82. Global Vaccine Adjuvants Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 83. Global Vaccine Adjuvants Revenue Market Share Forecast by Type (2021-2026)
Table 84. Global Vaccine Adjuvants Sales Forecast by Application (2021-2026) & (Kg)
Table 85. Global Vaccine Adjuvants Sales Market Share Forecast by Application (2021-2026)
Table 86. Global Vaccine Adjuvants Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 87. Global Vaccine Adjuvants Revenue Market Share Forecast by Application (2021-2026)
Table 88. SEPPIC Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 89. SEPPIC Vaccine Adjuvants Product Offered
Table 90. SEPPIC Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 91. SEPPIC Main Business
Table 92. SEPPIC Latest Developments
Table 93. SDA BIO Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 94. SDA BIO Vaccine Adjuvants Product Offered
Table 95. SDA BIO Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 96. SDA BIO Main Business
Table 97. SDA BIO Latest Developments
Table 98. Croda International Plc Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 99. Croda International Plc Vaccine Adjuvants Product Offered
Table 100. Croda International Plc Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 101. Croda International Plc Main Business
Table 102. Croda International Plc Latest Developments
Table 103. SPI Pharma Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 104. SPI Pharma Vaccine Adjuvants Product Offered
Table 105. SPI Pharma Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 106. SPI Pharma Main Business
Table 107. SPI Pharma Latest Developments
Table 108. Phibro Animal Health Corporation Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 109. Phibro Animal Health Corporation Vaccine Adjuvants Product Offered
Table 110. Phibro Animal Health Corporation Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 111. Phibro Animal Health Corporation Main Business
Table 112. Phibro Animal Health Corporation Latest Developments
Table 113. Tj Kaiwei Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 114. Tj Kaiwei Vaccine Adjuvants Product Offered
Table 115. Tj Kaiwei Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 116. Tj Kaiwei Main Business
Table 117. Tj Kaiwei Latest Developments
Table 118. Novavax Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 119. Novavax Vaccine Adjuvants Product Offered
Table 120. Novavax Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 121. Novavax Main Business
Table 122. Novavax Latest Developments
Table 123. Zhuoyue Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 124. Zhuoyue Vaccine Adjuvants Product Offered
Table 125. Zhuoyue Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 126. Zhuoyue Main Business
Table 127. Zhuoyue Latest Developments
Table 128. Aphios Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 129. Aphios Vaccine Adjuvants Product Offered
Table 130. Aphios Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 131. Aphios Main Business
Table 132. Aphios Latest Developments
Table 133. GSK Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 134. GSK Vaccine Adjuvants Product Offered
Table 135. GSK Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 136. GSK Main Business
Table 137. GSK Latest Developments
Table 138. CSL Limited Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 139. CSL Limited Vaccine Adjuvants Product Offered
Table 140. CSL Limited Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 141. CSL Limited Main Business
Table 142. CSL Limited Latest Developments
Table 143. Brenntag Biosector Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 144. Brenntag Biosector Vaccine Adjuvants Product Offered
Table 145. Brenntag Biosector Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 146. Brenntag Biosector Main Business
Table 147. Brenntag Biosector Latest Developments
Table 148. SEPPIC Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 149. SEPPIC Vaccine Adjuvants Product Offered
Table 150. SEPPIC Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 151. SEPPIC Main Business
Table 152. SEPPIC Latest Developments
Table 153. SPI Pharma Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 154. SPI Pharma Vaccine Adjuvants Product Offered
Table 155. SPI Pharma Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 156. SPI Pharma Main Business
Table 157. SPI Pharma Latest Developments
Table 158. Novavax Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 159. Novavax Vaccine Adjuvants Product Offered
Table 160. Novavax Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 161. Novavax Main Business
Table 162. Novavax Latest Developments
Table 163. Avanti Polar Lipids Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 164. Avanti Polar Lipids Vaccine Adjuvants Product Offered
Table 165. Avanti Polar Lipids Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 166. Avanti Polar Lipids Main Business
Table 167. Avanti Polar Lipids Latest Developments
Table 168. Aphios Basic Information, Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 169. Aphios Vaccine Adjuvants Product Offered
Table 170. Aphios Vaccine Adjuvants Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 171. Aphios Main Business
Table 172. Aphios Latest Developments
List of Figures
Figure 1. Picture of Vaccine Adjuvants
Figure 2. Vaccine Adjuvants Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vaccine Adjuvants Sales Growth Rate 2016-2026 (Kg)
Figure 7. Global Vaccine Adjuvants Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Vaccine Adjuvants Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of Subcutaneous
Figure 11. Product Picture of Intramuscular
Figure 12. Product Picture of Others
Figure 13. Global Vaccine Adjuvants Sales Market Share by Type in 2020
Figure 14. Global Vaccine Adjuvants Revenue Market Share by Type (2016-2021)
Figure 15. Vaccine Adjuvants Consumed in Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
Figure 16. Global Vaccine Adjuvants Market: Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications) (2016-2021) & (Kg)
Figure 17. Vaccine Adjuvants Consumed in Human Vaccine Adjuvants (Research Applications, Commercial Applications)
Figure 18. Global Vaccine Adjuvants Market: Human Vaccine Adjuvants (Research Applications, Commercial Applications) (2016-2021) & (Kg)
Figure 19. Global Vaccine Adjuvants Sales Market Share by Application (2016-2021)
Figure 20. Global Vaccine Adjuvants Revenue Market Share by Application in 2020
Figure 21. Vaccine Adjuvants Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Vaccine Adjuvants Revenue Market Share by Company in 2020
Figure 23. Global Vaccine Adjuvants Sales Market Share by Regions (2016-2021)
Figure 24. Global Vaccine Adjuvants Revenue Market Share by Region in 2020
Figure 25. Americas Vaccine Adjuvants Sales 2016-2021 (Kg)
Figure 26. Americas Vaccine Adjuvants Revenue 2016-2021 ($ Millions)
Figure 27. APAC Vaccine Adjuvants Sales 2016-2021 (Kg)
Figure 28. APAC Vaccine Adjuvants Revenue 2016-2021 ($ Millions)
Figure 29. Europe Vaccine Adjuvants Sales 2016-2021 (Kg)
Figure 30. Europe Vaccine Adjuvants Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Vaccine Adjuvants Sales 2016-2021 (Kg)
Figure 32. Middle East & Africa Vaccine Adjuvants Revenue 2016-2021 ($ Millions)
Figure 33. Americas Vaccine Adjuvants Sales Market Share by Country in 2020
Figure 34. Americas Vaccine Adjuvants Revenue Market Share by Country in 2020
Figure 35. Americas Vaccine Adjuvants Sales Market Share by Type in 2020
Figure 36. Americas Vaccine Adjuvants Sales Market Share by Application in 2020
Figure 37. United States Vaccine Adjuvants Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Vaccine Adjuvants Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Vaccine Adjuvants Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Vaccine Adjuvants Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Vaccine Adjuvants Sales Market Share by Region in 2020
Figure 42. APAC Vaccine Adjuvants Revenue Market Share by Regions in 2020
Figure 43. APAC Vaccine Adjuvants Sales Market Share by Type in 2020
Figure 44. APAC Vaccine Adjuvants Sales Market Share by Application in 2020
Figure 45. China Vaccine Adjuvants Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Vaccine Adjuvants Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Vaccine Adjuvants Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Vaccine Adjuvants Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Vaccine Adjuvants Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Vaccine Adjuvants Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Vaccine Adjuvants Sales Market Share by Country in 2020
Figure 52. Europe Vaccine Adjuvants Revenue Market Share by Country in 2020
Figure 53. Europe Vaccine Adjuvants Sales Market Share by Type in 2020
Figure 54. Europe Vaccine Adjuvants Sales Market Share by Application in 2020
Figure 55. Germany Vaccine Adjuvants Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Vaccine Adjuvants Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Vaccine Adjuvants Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Vaccine Adjuvants Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Vaccine Adjuvants Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Vaccine Adjuvants Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Vaccine Adjuvants Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Vaccine Adjuvants Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Vaccine Adjuvants Sales Market Share by Application in 2020
Figure 64. Egypt Vaccine Adjuvants Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Vaccine Adjuvants Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Vaccine Adjuvants Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Vaccine Adjuvants Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Vaccine Adjuvants Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
